| 1 |
Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis |
|
|
| Myra van Laar, Wouter A.C. van Amsterdam, Anne S.R. van Lindert, Pim A. de Jong, Joost J.C. Verhoeff |
|
| Radiotherapy and Oncology. 2020; 151: 152 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis |
|
|
| Shan xian Guo, Yan Jian, Ying lan Chen, Yun Cai, Qing yuan Zhang, Fang fang Tou |
|
| Scientific Reports. 2016; 6(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Surgery for Stage IIIA Non–Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It |
|
|
| Branislav Jeremic,Francesc Casas,Pavol Dubinsky,Antonio Gomez-Caamano,Nikola Cihoric,Greg Videtic |
|
| Clinical Lung Cancer. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non–small cell lung cancer |
|
|
| Chi-Fu Jeffrey Yang,Brian C. Gulack,Lin Gu,Paul J. Speicher,Xiaofei Wang,David H. Harpole,Mark W. Onaitis,Thomas A. DæAmico,Mark F. Berry,Matthew G. Hartwig |
|
| The Journal of Thoracic and Cardiovascular Surgery. 2015; 150(6): 1484 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer |
|
|
| Yan, D. and Wei, P. and An, G. and Chen, W. |
|
| Journal of Cardiothoracic Surgery. 2013; 8(1) |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer |
|
|
| Berry, M.F. and Worni, M. and Pietrobon, R. and DæAmico, T.A. and Akushevich, I. |
|
| Journal of Thoracic Oncology. 2013; 8(6): 744-752 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer |
|
|
| Mark F. Berry,Mathias Worni,Ricardo Pietrobon,Thomas A. D’Amico,Igor Akushevich |
|
| Journal of Thoracic Oncology. 2013; 8(6): 744 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer |
|
|
| Dong Yan,Ping Wei,Guangyu An,Wenming Chen |
|
| Journal of Cardiothoracic Surgery. 2013; 8(1): 149 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer |
|
|
| Asad A. Shah,Mark F. Berry,Ching Tzao,Mihir Gandhi,Mathias Worni,Ricardo Pietrobon,Thomas A. DæAmico |
|
| The Annals of Thoracic Surgery. 2012; 93(6): 1807 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer |
|
|
| Shah, A.A. and Berry, M.F. and Tzao, C. and Gandhi, M. and Worni, M. and Pietrobon, R. and DæAmico, T.A. |
|
| Annals of Thoracic Surgery. 2012; 93(6): 1807-1812 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer |
|
|
| T. Baba, H. Uramoto, T. Kuwata, Y. Chikaishi, M. Nakagawa, T. So, T. Hanagiri, F. Tanaka |
|
| Interactive Cardiovascular and Thoracic Surgery. 2012; |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 12 |
Superior vena cava syndrome in thoracic malignancies |
|
|
| Lepper, P.M., Ott, S.R., Hoppe, H., Schumann, C., Stammberger, U., Bugalho, A., Frese, S., (...), Hamacher, J. |
|
| Respiratory Care. 2011; 56(5): 653-666 |
|
| [Pubmed] [Google Scholar] |
|
